- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有114家主力机构披露2025-06-30报告期持股数据，持仓量总计7357.35万股，占流通A股14.67%
- 波段诊断：
-
技术面诊股
诊断结果：5.9技术面打败了36%的股票
技术面评分前10的股票
近期的平均成本为16.20元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为16.20元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.20","date":1763281515,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.11.17","stock":"-1.76","trade":"-1.38","ind":"-0.11"},{"date":"2025.11.14","stock":"-0.78","trade":"0.46","ind":"-1.93"},{"date":"2025.11.13","stock":"-0.18","trade":"1.48","ind":"1.78"},{"date":"2025.11.12","stock":"0.61","trade":"0.91","ind":"-0.36"},{"date":"2025.11.11","stock":"0.18","trade":"0.07","ind":"-1.03"},{"date":"2025.11.10","stock":"2.30","trade":"1.60","ind":"0.18"},{"date":"2025.11.07","stock":"-0.25","trade":"-1.27","ind":"-0.36"},{"date":"2025.11.06","stock":"-1.16","trade":"-0.08","ind":"1.73"},{"date":"2025.11.05","stock":"-0.43","trade":"-0.70","ind":"0.37"},{"date":"2025.11.04","stock":"-0.91","trade":"-2.01","ind":"-1.71"},{"date":"2025.11.03","stock":"1.72","trade":"0.44","ind":"0.19"},{"date":"2025.10.31","stock":"3.89","trade":"2.36","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.06","trade":"-1.20","ind":"-1.16"},{"date":"2025.10.29","stock":"-0.70","trade":"2.22","ind":"1.95"},{"date":"2025.10.28","stock":"0.13","trade":"-0.53","ind":"-0.44"},{"date":"2025.10.27","stock":"1.87","trade":"1.02","ind":"1.51"},{"date":"2025.10.24","stock":"1.78","trade":"1.41","ind":"2.02"},{"date":"2025.10.23","stock":"0.00","trade":"-0.34","ind":"0.22"},{"date":"2025.10.22","stock":"-0.59","trade":"-0.68","ind":"-0.62"},{"date":"2025.10.21","stock":"1.26","trade":"1.23","ind":"2.06"},{"date":"2025.10.20","stock":"1.00","trade":"1.65","ind":"0.98"}]
迪安诊断,深证成指,医疗服务指数
压力支撑
该股压力位为16.23元，支撑位为16.04元。
[{"text":"\u538b\u529b\u4f4d","value":"16.23","date":1763308800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.04","date":1763308800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.6资金面打败了13%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月17日 20:34
| 机构今日流向(万元) | -3194.31 | 机构5日流向(万元) | -2804.66 |
| 机构10日流向(万元) | -8983.15 | 机构20日流向(万元) | -14847.21 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3103.77万股，其中基金净减仓24家，主力净减仓48家，请投资者中长期谨慎为宜。
截止2025-06-30，共114家主力机构（基金110家，一般法人2家，QFII2家），持仓量总计7357.35万股，占流通A股14.67%
其中，基金持仓与2024-12-31相比：
增仓：15家 ，增持 169.69万股
减仓：39家 ，减持 141.13万股
新出现在主力名单中：51家 ，持有3146.56万股
从主力名单中消失：99家 ，原持有4668.44万股
其中，基金持仓与2024-12-31相比：
增仓：15家 ，增持 169.69万股
减仓：39家 ，减持 141.13万股
新出现在主力名单中：51家 ，持有3146.56万股
从主力名单中消失：99家 ，原持有4668.44万股
消息面诊股
诊断结果：5.5消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 迪安诊断：11月14日获融资买入2321.10万元
2025-11-17 - 券商观点|计算机行业周报：哪些AI应用值得中期投资
2025-11-17 - 生物制造被提到新高度 创新药、中药等细分领域备受关
2025-11-14 - 行业周报|医疗服务指数涨4.60%, 跑赢上证指数
2025-11-14 - 迪安诊断：11月12日获融资买入1986.06万元
2025-11-13 - 国产替代+场景扩容+科研突破！基因测序获第四代技术
2025-11-12 - 新增10家！迪安诊断“筛诊同行”方案再扩容，肿瘤早
2025-11-12 - 迪安诊断：11月11日获融资买入2240.33万元
2025-11-12 - 迪安诊断：11月10日获融资买入3098.21万元
2025-11-11 - 迪安诊断：公司于2024年通过集中竞价方式累计回购
2025-11-10
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-03 |
| 一般消息 | 高管变动 | 因公司内部岗位调整 | 2025-10-13 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-09-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-23 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-23 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-02 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.5行业面打败了71%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.11.17","price":"-0.11","value":"-1.38"},{"date":"2025.11.14","price":"-1.93","value":"0.46"},{"date":"2025.11.13","price":"1.78","value":"1.48"},{"date":"2025.11.12","price":"-0.36","value":"0.91"},{"date":"2025.11.11","price":"-1.03","value":"0.07"},{"date":"2025.11.10","price":"0.18","value":"1.60"},{"date":"2025.11.07","price":"-0.36","value":"-1.27"},{"date":"2025.11.06","price":"1.73","value":"-0.08"},{"date":"2025.11.05","price":"0.37","value":"-0.70"},{"date":"2025.11.04","price":"-1.71","value":"-2.01"},{"date":"2025.11.03","price":"0.19","value":"0.44"},{"date":"2025.10.31","price":"-1.14","value":"2.36"},{"date":"2025.10.30","price":"-1.16","value":"-1.20"},{"date":"2025.10.29","price":"1.95","value":"2.22"},{"date":"2025.10.28","price":"-0.44","value":"-0.53"},{"date":"2025.10.27","price":"1.51","value":"1.02"},{"date":"2025.10.24","price":"2.02","value":"1.41"},{"date":"2025.10.23","price":"0.22","value":"-0.34"},{"date":"2025.10.22","price":"-0.62","value":"-0.68"},{"date":"2025.10.21","price":"2.06","value":"1.23"},{"date":"2025.10.20","price":"0.98","value":"1.65"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 诚达药业 | 39.90% | 46.38% | 6.4分 |
| 2 | ST中珠 | 29.03% | 23.71% | 5.7分 |
| 3 | - | 27.69% | 4.22% | 分 |
| 4 | 诺思格 | 18.97% | -4.45% | 4.9分 |
| 5 | 百花医药 | 17.45% | 17.71% | 6.9分 |
| 6 | 九洲药业 | 16.08% | 10.07% | 6.8分 |
| 8 | 皓宸医疗 | 12.54% | 4.06% | 6.5分 |
| 10 | 澳洋健康 | 11.65% | 1.10% | 6.4分 |
| 12 | 光正眼科 | 10.91% | 4.50% | 6.7分 |
| 14 | 美年健康 | 8.22% | 0.91% | 6.0分 |
| 16 | 贝瑞基因 | 7.22% | 0.00% | 5.3分 |
| 18 | 华厦眼科 | 7.20% | 1.24% | 7.0分 |
| 20 | 金域医学 | 7.17% | 0.53% | 5.3分 |
| 22 | 何氏眼科 | 6.23% | 0.18% | 5.7分 |
| 24 | 成都先导 | 5.69% | 4.18% | 5.6分 |
| 26 | 普蕊斯 | 4.85% | -3.33% | 5.3分 |
| 28 | 华大基因 | 3.97% | -1.33% | 5.1分 |
| 30 | 国际医学 | 2.69% | 1.64% | 6.6分 |
| 32 | 新里程 | 2.12% | 2.99% | 6.4分 |
| 34 | 奥浦迈 | 0.64% | -7.39% | 5.1分 |
| 36 | 睿智医药 | 0.00% | 3.12% | 5.4分 |
| 38 | 药石科技 | -1.32% | -2.09% | 4.4分 |
| 40 | 爱尔眼科 | -1.54% | -2.57% | 6.1分 |
| 42 | 阳光诺和 | -3.08% | 4.75% | 6.1分 |
| 44 | 海特生物 | -4.09% | -2.58% | 4.1分 |
| 46 | 药明康德 | -5.19% | 0.33% | 6.1分 |
| 48 | 三博脑科 | -6.08% | -3.01% | 4.6分 |
| 50 | 皓元医药 | -8.23% | -5.81% | 5.4分 |
| 52 | 百诚医药 | -10.28% | -1.32% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 33/100 ， 35/100。
[{"date":"2025-09-30","value":"0.87","vol":"3.15"},{"date":"2025-06-30","value":"0.16","vol":"2.23"},{"date":"2025-03-31","value":"-0.32","vol":"0.92"},{"date":"2024-12-31","value":"-5.06","vol":"-0.15"},{"date":"2024-09-30","value":"1.79","vol":"3.24"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.87 | 0.16 | -0.32 | -5.06 | 1.79 |
| 行业(%) | 3.15 | 2.23 | 0.92 | -0.15 | 3.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"29.07","vol":"35.90"},{"date":"2025-06-30","value":"27.59","vol":"36.06"},{"date":"2025-03-31","value":"26.39","vol":"34.67"},{"date":"2024-12-31","value":"28.01","vol":"34.77"},{"date":"2024-09-30","value":"28.05","vol":"36.16"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.07 | 27.59 | 26.39 | 28.01 | 28.05 |
| 行业(%) | 35.90 | 36.06 | 34.67 | 34.77 | 36.16 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 46/100 ， 43/100。
[{"date":"2025-09-30","value":"-18.28","vol":"2.47"},{"date":"2025-06-30","value":"-20.61","vol":"2.42"},{"date":"2025-03-31","value":"-20.45","vol":"-0.08"},{"date":"2024-12-31","value":"-9.04","vol":"-0.73"},{"date":"2024-09-30","value":"-10.05","vol":"0.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-18.28 | -20.61 | -20.45 | -9.04 | -10.05 |
| 行业(%) | 2.47 | 2.42 | -0.08 | -0.73 | 0.87 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-56.67","vol":"15.81"},{"date":"2025-06-30","value":"-85.68","vol":"-71.46"},{"date":"2025-03-31","value":"-190.66","vol":"-25.93"},{"date":"2024-12-31","value":"-216.20","vol":"-96.53"},{"date":"2024-09-30","value":"-75.35","vol":"-161.08"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-56.67 | -85.68 | -190.66 | -216.20 | -75.35 |
| 行业(%) | 15.81 | -71.46 | -25.93 | -96.53 | -161.08 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 4/100 ， 27/100。
[{"date":"2025-09-30","value":"0.50","vol":"0.31"},{"date":"2025-06-30","value":"0.32","vol":"0.20"},{"date":"2025-03-31","value":"0.15","vol":"0.10"},{"date":"2024-12-31","value":"0.72","vol":"0.41"},{"date":"2024-09-30","value":"0.53","vol":"0.31"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.50 | 0.32 | 0.15 | 0.72 | 0.53 |
| 行业(次) | 0.31 | 0.20 | 0.10 | 0.41 | 0.31 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.38","vol":"11.36"},{"date":"2025-06-30","value":"2.19","vol":"7.41"},{"date":"2025-03-31","value":"1.07","vol":"3.76"},{"date":"2024-12-31","value":"5.59","vol":"16.35"},{"date":"2024-09-30","value":"4.03","vol":"14.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.38 | 2.19 | 1.07 | 5.59 | 4.03 |
| 行业(次) | 11.36 | 7.41 | 3.76 | 16.35 | 14.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"22.59","vol":"16.21"},{"date":"2025-06-30","value":"17.38","vol":"15.87"},{"date":"2025-03-31","value":"-7.15","vol":"-1.69"},{"date":"2024-12-31","value":"39.25","vol":"22.34"},{"date":"2024-09-30","value":"10.96","vol":"12.23"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 22.59 | 17.38 | -7.15 | 39.25 | 10.96 |
| 行业 | 16.21 | 15.87 | -1.69 | 22.34 | 12.23 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.49","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.49 | - | 0.50 | - |
| 行业 | 0.00 | 0.94 | 0.00 | 1.31 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/100 ， 29/100。
[{"date":"2025-09-30","value":"2.74","vol":"3.81"},{"date":"2025-06-30","value":"2.68","vol":"3.69"},{"date":"2025-03-31","value":"2.65","vol":"3.84"},{"date":"2024-12-31","value":"2.54","vol":"3.70"},{"date":"2024-09-30","value":"2.61","vol":"4.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.74 | 2.68 | 2.65 | 2.54 | 2.61 |
| 行业 | 3.81 | 3.69 | 3.84 | 3.70 | 4.11 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.22","vol":"3.06"},{"date":"2025-06-30","value":"2.15","vol":"2.98"},{"date":"2025-03-31","value":"2.16","vol":"3.12"},{"date":"2024-12-31","value":"2.08","vol":"3.01"},{"date":"2024-09-30","value":"2.12","vol":"3.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.22 | 2.15 | 2.16 | 2.08 | 2.12 |
| 行业 | 3.06 | 2.98 | 3.12 | 3.01 | 3.38 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 7/100 ， 11/100。
[{"date":"2025-09-30","value":"41.25","vol":"31.72"},{"date":"2025-06-30","value":"43.01","vol":"32.65"},{"date":"2025-03-31","value":"42.54","vol":"32.24"},{"date":"2024-12-31","value":"44.46","vol":"32.31"},{"date":"2024-09-30","value":"44.50","vol":"31.03"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
41.25 | 43.01 | 42.54 | 44.46 | 44.50 |
| 行业(%) | 31.72 | 32.65 | 32.24 | 32.31 | 31.03 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.94","vol":"0.91"},{"date":"2025-06-30","value":"1.01","vol":"0.95"},{"date":"2025-03-31","value":"0.99","vol":"0.98"},{"date":"2024-12-31","value":"1.07","vol":"1.01"},{"date":"2024-09-30","value":"1.08","vol":"0.85"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.94 | 1.01 | 0.99 | 1.07 | 1.08 |
| 行业(%) | 0.91 | 0.95 | 0.98 | 1.01 | 0.85 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中泰证券 | 2025-11-03 | 买入 | 买入 |
| 中国银河 | 2025-10-29 | 买入 | 买入 |
| 东方证券 | 2025-08-27 | 买入 | |
| 中信证券 | 2025-08-26 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"11.63","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"14.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.30","blueLineValue":"0.21","type":"YC"}]